about us

our services

the library

contact us

Meet our
Principals

| AN OVERVIEW |
| OUR HISTORY |
| WHY INOVIS? |
| MEET OUR PRINCIPALS |
| THE INOVIS DIFFERENCE |
| OUR STEADFAST CLIENT BASE |
| CAREERS AT INOVIS |

experienced in their field

marc@inovis.global

Marc Limacher, MBA
Founder and CEO
INOVIS

View Marc Limacher's profile on LinkedIn

Marc Limacher started INOVIS in 1992 as a boutique primary CI specialty firm in Palo Alto, CA, focusing strictly on the pharma/biotech (12 therapy areas, medical devices/diagnostics, telehealth) and IT industries (including cloud infrastructure & software, enterprise software & applications across 10 industry verticals, social media, hardware, & IT services).

As a 26-year veteran in the CI and counter-intelligence industry, he has grown INOVIS into a global leader in primary intelligence & strategic consulting services, counting a select group of global Fortune 100 companies as loyal clients. The introduction of an expert regulatory intelligence practice is unique in the industry. He is responsible for the overall strategic direction of the firm and manages the operation of the IT/telco practice.

Prior to INOVIS, Marc was Director of Market Intelligence at a leading U.S. institutional investment firm for five years, providing primary intelligence on small-/medium-/large-cap life science equities via a global employee network of 125 investigative journalists. He also delivers private CI seminars and is a frequent lecturer on CI and counter-intelligence topics at companies and to academia.

Marc is fluent in 5 languages and enjoys the proximity to the ski slopes from the Lucerne office, the proximity to the Pacific waves from the Palo Alto office, and the proximity to NYC from the Princeton office.

baljit@inovis.global

Baljit Singh, PhD
Managing Director and Partner,
Global Pharmaceuticals & Life Sciences Division
INOVIS

View Baljit Singh (Ph.D.)'s profile on LinkedIn

Baljit Singh comes to the company from Novartis Pharma AG, where he most recently served as Global Director of Integrated Insights and helped to develop competitive intelligence (CI) functions and processes which are still in effect today. In addition to leading numerous competitor simulations and strategic scenario planning workshops, Dr. Singh spearheaded Novartis most comprehensive generics CI tracking program, earning him, as part of a cross-functional team, the highest honors within the global commercial organization.

Previously, Dr. Singh worked as Head of Competitive Intelligence for a major Generics and Biosimilar intelligence firm to help pharmaceutical clients optimize their lifecycle strategies.

Baljit has experience in the global pharmaceutical, biotech and generics markets,leading in-depth analyses and recommendations from development to commercial strategic projects. He joined Novartis Pharma AG in early 2010 and was responsible for Competitive Intelligence for the Global Respiratory Franchise and subsequently the Global Primary Care Franchise. During this time he led the most comprehensive Generic tracking program in Novartis focusing on vertical structures, regulatory issues, clinical issues and patent issues. He joined Novartis Pharma AG from a consultancy company where he was Head of Research.

Baljit studied pharmacy at the Royal Danish School of Pharmacy in Copenhagen, Denmark and received his Ph.D in Pharmaceutics from London School of Pharmacy in 2006. He has also played cricket for the Danish National team for ~10 Years.

© INOVIS Inc. All Rights Reserved
| web site map |

US | EAST COAST
PH 1.305.913.1350
info@inovis.global

US | WEST COAST
PH 1.650.298.8555
info@inovis.global

EUROPE | LUCERNE
PH 41.41.455.2522
info@inovis.global

site designed and maintained by tmwstudio